[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 821011, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Steegmaier Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.28, "open": 4.3887, "dayLow": 4.33, "dayHigh": 4.39, "regularMarketPreviousClose": 4.28, "regularMarketOpen": 4.3887, "regularMarketDayLow": 4.33, "regularMarketDayHigh": 4.39, "payoutRatio": 0.0, "beta": 0.563, "forwardPE": -3.7096424, "volume": 3211, "regularMarketVolume": 3211, "averageVolume": 5319, "averageVolume10days": 4170, "averageDailyVolume10Day": 4170, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 164182272, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 5.91, "allTimeHigh": 32.04, "allTimeLow": 3.32, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 4.06184, "twoHundredDayAverage": 3.8873, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 61193276, "profitMargins": 0.0, "floatShares": 17489339, "sharesOutstanding": 37399152, "sharesShort": 26423, "sharesShortPriorMonth": 24180, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0007, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.095790006, "shortRatio": 2.78, "shortPercentOfFloat": 0.0014, "impliedSharesOutstanding": 37399152, "bookValue": 3.2160478, "priceToBook": 1.3650295, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -60234000, "trailingEps": -2.04, "forwardEps": -1.1834024, "enterpriseToEbitda": -1.078, "52WeekChange": -0.21323532, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 4.39, "targetHighPrice": 17.054575, "targetLowPrice": 3.7994113, "targetMeanPrice": 10.771395, "targetMedianPrice": 11.115794, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 104521000, "totalCashPerShare": 2.795, "ebitda": -56742000, "totalDebt": 1532000, "quickRatio": 9.081, "currentRatio": 9.28, "totalRevenue": 0, "debtToEquity": 1.604, "revenuePerShare": 0.0, "returnOnAssets": -0.27014, "returnOnEquity": -0.51415, "grossProfits": -40403000, "freeCashflow": -27220124, "operatingCashflow": -53301000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1766187782, "regularMarketTime": 1766178000, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "earningsTimestampStart": 1756152000, "earningsTimestampEnd": 1756152000, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.04, "epsForward": -1.1834024, "epsCurrentYear": -1.48572, "priceEpsCurrentYear": -2.954796, "twoHundredDayAverageChangePercent": 0.1293185, "fiftyDayAverageChange": 0.3281598, "fiftyDayAverageChangePercent": 0.08079092, "twoHundredDayAverageChange": 0.50269985, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 2.5700853, "regularMarketPrice": 4.39, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": 6.8337173, "postMarketPrice": 4.69, "postMarketChange": 0.3000002, "regularMarketChange": 0.10999966, "regularMarketDayRange": "4.33 - 4.39", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5319, "fiftyTwoWeekLowChange": 1.03, "fiftyTwoWeekLowChangePercent": 0.3065476, "fiftyTwoWeekRange": "3.36 - 5.91", "fiftyTwoWeekHighChange": -1.52, "fiftyTwoWeekHighChangePercent": -0.2571912, "fiftyTwoWeekChangePercent": -21.323532, "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]